282 related articles for article (PubMed ID: 6225965)
1. The origin of androgen synthesis in polycystic ovary syndrome.
Milewicz A; Silber D; Mielecki T
Obstet Gynecol; 1983 Nov; 62(5):601-4. PubMed ID: 6225965
[TBL] [Abstract][Full Text] [Related]
2. Polycystic ovarian disease: the adrenal connection.
Marouliss GB; Triantafillidis IK
Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():205-7. PubMed ID: 16641861
[TBL] [Abstract][Full Text] [Related]
3. Determination of the source(s) of androgen overproduction in hirsutism associated with polycystic ovary syndrome by simultaneous adrenal and ovarian venous catheterization. Comparison with the dexamethasone suppression test.
Wajchenberg BL; Achando SS; Okada H; Czeresnia CE; Peixoto S; Lima SS; Goldman J
J Clin Endocrinol Metab; 1986 Nov; 63(5):1204-10. PubMed ID: 3760120
[TBL] [Abstract][Full Text] [Related]
4. Hirsutism and hyperandrogenism.
Givens JR
Adv Intern Med; 1976; 21():221-47. PubMed ID: 130060
[No Abstract] [Full Text] [Related]
5. The postmenopausal ovary is not a major androgen-producing gland.
Couzinet B; Meduri G; Lecce MG; Young J; Brailly S; Loosfelt H; Milgrom E; Schaison G
J Clin Endocrinol Metab; 2001 Oct; 86(10):5060-6. PubMed ID: 11600585
[TBL] [Abstract][Full Text] [Related]
6. The androgenic polycystic ovary.
Greenblatt RB; Mahesh VB
Am J Obstet Gynecol; 1976 Jul; 125(5):712-26. PubMed ID: 180807
[TBL] [Abstract][Full Text] [Related]
7. Idiopathic hirsutism--an ovarian abnormality.
Kirschner MA; Zucker IR; Jespersen D
N Engl J Med; 1976 Mar; 294(12):637-40. PubMed ID: 1246257
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone suppressibility and adrenal and ovarian venous effluents of 5α-reduced C19 conjugates in hyperandrogenic women.
Stanczyk FZ; Saxena T; Lobo RA
J Steroid Biochem Mol Biol; 2014 Jan; 139():73-7. PubMed ID: 24121067
[TBL] [Abstract][Full Text] [Related]
9. [Androgen response in women with polycystic ovary syndrome and hyperinsulinemia during stimulation with corticotrophin and inhibition with dexamethasone].
Espinosa de los Monteros A; Guerra de la Garza A; Barrón J; Parra A
Rev Invest Clin; 1996; 48(4):267-73. PubMed ID: 8966389
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the adrenal-ovarian contribution by short-term dexamethasone and ACTH tests in hyperandrogenized patients.
Fulghesu AM; Lanzone A; Apa R; Fortini A; Caruso A; Mancuso S
Gynecol Endocrinol; 1991 Mar; 5(1):37-48. PubMed ID: 1654730
[TBL] [Abstract][Full Text] [Related]
11. Evidence of excessive androgen secretion by both the ovary and the adrenal in patients with idiopathic hirsutism.
Pugeat M; Forest MG; Nisula BC; Corniau J; De Peretti E; Tourniaire J
Obstet Gynecol; 1982 Jan; 59(1):46-51. PubMed ID: 6804896
[TBL] [Abstract][Full Text] [Related]
12. Are adrenal and testicular androgen levels correlated?
Georgiadis EI; Matzoros C; Aliferis C; Batrinos M
Horm Metab Res; 1992 Oct; 24(10):488-91. PubMed ID: 1464416
[TBL] [Abstract][Full Text] [Related]
13. Possible metformin effect on adrenal androgens during pretreatment and IVF cycle in women with polycystic ovary syndrome.
Kjøtrød SB; Sunde A; von Düring V; Carlsen SM
Fertil Steril; 2009 Feb; 91(2):500-8. PubMed ID: 18304542
[TBL] [Abstract][Full Text] [Related]
14. Androgen and estrogen formation in women with ovarian hyperthecosis.
Aiman J; Edman CD; Worley RJ; Vellios F; MacDonald PC
Obstet Gynecol; 1978 Jan; 51(1):1-9. PubMed ID: 619322
[TBL] [Abstract][Full Text] [Related]
15. Is ovarian and adrenal venous catheterization and sampling helpful in the investigation of hyperandrogenic women?
Kaltsas GA; Mukherjee JJ; Kola B; Isidori AM; Hanson JA; Dacie JE; Reznek R; Monson JP; Grossman AB
Clin Endocrinol (Oxf); 2003 Jul; 59(1):34-43. PubMed ID: 12807501
[TBL] [Abstract][Full Text] [Related]
16. Abnormal production of androgens in women with breast cancer.
Secreto G; Zumoff B
Anticancer Res; 1994; 14(5B):2113-7. PubMed ID: 7840509
[TBL] [Abstract][Full Text] [Related]
17. Possibility of adrenal-testicular interaction as indicated by plasma androgens in response to HCG in men with normal, suppressed and impaired adrenal function.
Nieschlag E; Kley HK
Horm Metab Res; 1975 Jul; 7(4):326-30. PubMed ID: 125219
[TBL] [Abstract][Full Text] [Related]
18. Gonadal and adrenal androgen secretion in hirsute females.
Molta L; Schwartz U
Clin Endocrinol Metab; 1986 May; 15(2):229-45. PubMed ID: 2941187
[TBL] [Abstract][Full Text] [Related]
19. Combined dexamethasone and human chorionic gonadotropin in diagnosis of polycystic ovarian disease.
Beck WW; McEvoy D; Wallach EE
Obstet Gynecol; 1971 Feb; 37(2):211-7. PubMed ID: 5539356
[No Abstract] [Full Text] [Related]
20. Serum 11 beta-hydroxyandrostenedione as an indicator of the source of excess androgen production in women with polycystic ovaries.
Polson DW; Reed MJ; Franks S; Scanlon MJ; James VH
J Clin Endocrinol Metab; 1988 May; 66(5):946-50. PubMed ID: 3129451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
